Skip to main content
Premium Trial:

Request an Annual Quote

Ghent to Use Roche's LightCycler in Cancer Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Scientists at Ghent University in Belgium will use Roche's LightCycler 1536 in various cancer research projects, the company said today.

Ghent researchers will use the technology for multi-gene expression signature profiling on cancer research samples and for digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.

The school also will use the LightCycler in studies involving DNA methylation analysis, copy number variant screening, and amplicon generation for next-generation sequencing efforts. One study will use qPCR-based transcriptome-wide profiling in a pilot experiment that will involve measuring genes in reference RNA samples, said Roche.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.